Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept & continue
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
    Most Read
    • Donald Trump’s Mar-a-Lago residence raided by FBI agents
    • Finland and Estonia urge EU to stop issuing tourist visas to Russians
    • Xi Jinping grasps ‘knife’ of internal security to complete grip on power
    • Justice Department under pressure to explain raid on Trump’s estate
    • Taipei accuses Beijing of trying to take control of Taiwan Strait
  • US
    Sections
    • US Home
    • US Economy
    • US Companies
    • US Politics & Policy
    Most Read
    • Companies
      Sections
      • Companies Home
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
      Most Read
      • Carlyle boss quit after failed request for $300mn pay package
      • Corporate America fumes over Biden’s tax and climate package
      • London’s ‘magic circle’ law firms make renewed bid to crack US
      • Carlyle’s chief executive resigns after breakdown in contract talks
      • BioNTech and Pfizer to begin vaccine clinical trial for new Covid variants
    • Tech
    • Markets
      Sections
      • Markets Home
      • Alphaville
      • Markets Data
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
      • Cryptofinance
      Most Read
      • Live news updates from August 9: Explosions shake air base in Crimea, SoftBank shares drop on $23bn loss
      • Investors divided over how long Big Tech rally will last
      • Corporate lawyers take it easy as US IPO market dries up
      • Investors sell stakes in buyout funds at a record pace
      • Energy companies urge UK to detoxify gas exports to EU
    • Climate
    • Opinion
      Sections
      • Opinion Home
      • Columnists
      • The FT View
      • The Big Read
      • Lex
      • Obituaries
      • Letters
      Most Read
      • Where have all the UK’s self-employed gone?
      • It is too early to declare risk of US recession is over
      • Dangerous fatalism about a US-China war
      • Europe can withstand a winter recession
      • Don’t rule out a fifth term for the Tories
    • Work & Careers
      Sections
      • Work & Careers Home
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
      Most Read
      • Can a city be redesigned for the new world of work?
      • Brompton’s Will Butler-Adams: ‘People have no idea what goes into a product. That’s not a good thing’
    • Life & Arts
      Sections
      • Life & Arts Home
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
      Most Read
      • Netflix aims to become a serious player in the gaming sphere
      • The best new watersports gear
      • Hauser & Wirth CEO Ewan Venters’ ideal London weekend
      • Gentle parenting, yes or no? FT readers respond
      • Tourists by Lucy Lethbridge — should have stayed at home?
    • HTSI
    MenuSearch
    • Home
    • World
    • US
    • Companies
    • Tech
    • Markets
    • Climate
    • Opinion
    • Work & Careers
    • Life & Arts
    • HTSI
    Financial Times
    SubscribeSign In

    Your guide to a disrupted world

    Start a 4-week trial

    Medical science

    Add to myFT Digest

    Add this topic to your myFT Digest for news straight to your inbox

    • Tuesday, 9 August, 2022
      Monkeypox
      UK supplies of monkeypox vaccine in danger of running out this month

      NHS warns higher-than-expected demand leaves it facing acute shortages until new shipments in late September

    • Tuesday, 9 August, 2022
      Coronavirus pandemic
      Tibetan cities locked down over first Covid outbreak in two years

      Historic Potala Palace closed as mass testing rolled out in Lhasa to contain Omicron variant

    • Monday, 8 August, 2022
      Pharmaceuticals sector
      Pfizer tests vaccine to fend off spread of tick-borne Lyme disease

      US drugmaker and French partner begin late-stage trial with 14% of global population showing evidence of infection

    • Monday, 8 August, 2022
      Stephen Bush
      Why courts have a place in policy debates

      The Archie Battersbee case shows that some disputes are better settled judicially

    • Monday, 8 August, 2022
      Monkeypox
      European men struggle to access monkeypox jabs

      Some people are travelling abroad to get vaccinated in wake of severe shortages and increasing case numbers

    • Thursday, 4 August, 2022
      Monkeypox
      US declares public health emergency over rapid spread of monkeypox

      Decision will allow Biden administration to tap new resources to combat disease amid criticism over its response

    • Wednesday, 3 August, 2022
      Scientists revive cells and tissues in dead pigs

      Yale research could expand donor organ availability but blurs boundary between life and death

    • Tuesday, 2 August, 2022
      Monkeypox
      Biden appoints team to tackle fast-spreading monkeypox outbreak

      Move follows declarations of emergency by California and Illinois amid growing criticism of US government’s response

    • Saturday, 30 July, 2022
      Joe Biden
      Joe Biden tests positive for Covid again, White House says

      President’s doctor says 79-year-old has ‘rebound’ case of coronavirus but no symptoms

    • Friday, 29 July, 2022
      National Health Service
      UK blood scandal victims due ‘no less than £100,000 in compensation’

      Scale of NHS treatment disaster implies £400mn bill for those ‘living on borrowed time’

    • Friday, 29 July, 2022
      Karen Petrou
      Biomedical financing must not be a casualty of the current downturn

      If the funding of small companies is threatened, then vital and transformative research will stop

    • Friday, 29 July, 2022
      Coronavirus pandemic
      Covid infections fall in England, Wales and Scotland

      Although trend in Northern Ireland is ‘uncertain’, latest data suggest virus wave may be in retreat

    • Thursday, 28 July, 2022
      First genetic treatment for inherited heart disease receives £30mn funding

      Injectable cure for congenital cardiomyopathies could be available within a few years, says UK charity

    • Thursday, 28 July, 2022
      Deepmind Technologies Ltd
      DeepMind research cracks structure of almost every known protein

      Breakthrough by Alphabet-owned AI company will significantly reduce time required to make biological discoveries

    • Tuesday, 26 July, 2022
      Monkeypox
      Global disease body to work with UK agencies on monkeypox vaccines

      Funding from Coalition for Epidemic Preparedness Innovations to ‘create critical tools’ to assess jabs

    • Tuesday, 26 July, 2022
      Anjana Ahuja
      To combat disease, science must look beyond the Kardashian of proteins

      P53 is the most studied protein in the human body, but researchers are expanding their horizons

    • Monday, 25 July, 2022
      Coronavirus treatment
      Slow uptake of Pfizer’s Covid drug hints at end to sales boom

      Paxlovid dominates antiviral treatment market but weak demand could cause supply glut, data group says

    • Monday, 25 July, 2022
      Biotech
      KKR backs medicine start-up as private equity pushes into sector

      A total of $55mn raised by genome specialist Replay comes amid wider interest among large investors

    • Saturday, 23 July, 2022
      Monkeypox
      WHO declares spread of monkeypox an international public health emergency

      Highest possible designation used for first time since Covid pandemic began as 16,000 cases detected across the world

    • Saturday, 23 July, 2022
      Australia
      Australia set to give its 69mn sheep IDs as foot and mouth fears rise

      Biosecurity procedures put to the test as Indonesian outbreak of livestock disease spreads

    • Thursday, 21 July, 2022
      Joe Biden
      Joe Biden has contracted Covid, White House says

      US president has ‘very mild symptoms’ and is taking Pfizer antiviral pill

    • Tuesday, 19 July, 2022
      Special ReportFT Health: Future of Antibiotics
      Antibiotic resistance raises prospect of untreatable gonorrhoea

      Just one drug remains effective for the sexually transmitted disease but soon the bacteria may be able to evade it

    • Tuesday, 19 July, 2022
      Special ReportFT Health: Future of Antibiotics
      Drug-resilient bacteria threat rises with spread of world’s war zones

      Infected wounds are growing cause for concern in the Middle East, Ukraine and beyond

    • Monday, 18 July, 2022
      Anthony Fauci
      US chief medical adviser Fauci to step down during Biden’s first term

      Head of national infectious disease institute says he will leave post by January 2025

    • Monday, 18 July, 2022
      Coronavirus pandemic
      China braced for renewed lockdowns as Omicron subvariant spreads

      Shanghai and Tianjin order mass testing as infectious BA.5 strain threatens economic recovery

    Previous page You are on page 1 Next page

    Useful links

    Support

    View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

    Legal & Privacy

    Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

    Services

    Share News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on TwitterFT ChannelsSecondary Schools

    Tools

    PortfolioToday's Newspaper (ePaper)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

    Community & Events

    FT CommunityFT LiveFT ForumsFT Board DirectorBoard Director Programme

    More from the FT Group

    Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2022. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
    The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
    Financial Times

    International Edition

    Subscribe for full access
    • Switch to UK Edition
    • Top sections
    • Home
    • World
      • Global Economy
      • UK
      • US
      • China
      • Africa
      • Asia Pacific
      • Emerging Markets
      • Europe
      • War in Ukraine
      • Americas
      • Middle East & North Africa
      • Australia & NZ
    • US
      • US Economy
      • US Companies
      • US Politics & Policy
    • Companies
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
    • Tech
    • Markets
      • Alphaville
      • Markets Data
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
      • Cryptofinance
    • Climate
    • Opinion
      • Columnists
      • The FT View
      • The Big Read
      • Lex
      • Obituaries
      • Letters
    • Work & Careers
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
    • Life & Arts
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
    • Personal Finance
      • Property & Mortgages
      • Investments
      • Pensions
      • Tax
      • Banking & Savings
      • Advice & Comment
      • Next Act
    • HTSI
    • Special Reports
    • FT recommends
    • Lex
    • Alphaville
    • Lunch with the FT
    • FT Globetrotter
    • #techAsia
    • Moral Money
    • FTfm
    • Newsletters
    • Video
    • Podcasts
    • News feed
    • FT Community
      • FT Live
      • FT Forums
      • Board Director Programme
    • myFT
    • Portfolio
    • Today's Newspaper (ePaper)
    • Crossword
    • Our Apps
    • Help Centre
    • Subscribe
    • Sign In